Argos Therapeutics Inc. (Nasdaq:ARGS), an immuno-oncology company headquartered in Durham, announced the appointment of Richard Morrison to the company's board of directors.
Morrison will serve as a Class III director and will serve on the audit committee of the board of directors, according to a news release. Officials with the company say he brings a wealth of pharmaceutical industry and financial expertise, as well as significant prior board level experience, to the Argos board of directors.
Morrison spent the majority of his career at Eli Lilly, where he served for 30 years in a variety of international leadership roles, including president and general manager of Lilly's operations in Latin America.
Prior to heading the Latin American companies, Morrison held several marketing and executive management positions in Europe, Africa and the Middle East, in both the pharmaceutical and agricultural divisions of the company.
For three years during a period of very difficult macro-economics in Latin America, and certain other international markets, he lead a special group working to restructure the Lilly Latin American affiliates and operations, especially relating to organization and rationalization of manufacturing, officials said.
His strategic work extended to Lilly Canada and Lilly Australia as well. Following his retirement from Eli Lilly in 1993, Morrison served on the faculty of the Cameron School of Business at the University of North Carolina Wilmington.
"We are delighted to welcome Dr. Morrison to the Argos board," said Hubert Birner, chairman of the Argos board of directors, in the release. "Dick has considerable pharmaceutical industry and financial expertise, and we look forward to the benefit of his experience as we seek to advance our novel pipeline of individualized immunotherapies directed at important diseases, including metastatic renal cell carcinoma and HIV. In particular, Dick's international and commercial experience will complement the expertise of the current board members as well as add a valuable new perspective."
Morrison has served on a number of boards of directors of companies in the medical industry, including AAIPharma, now called Alcami, a public pharmaceutical company.
Morrison holds masters and Ph.D. degrees from Louisiana State University and bachelors of science degree from Stephen F. Austin University in East Texas. He also served in the U.S. Navy. He has served on the boards of numerous charitable organizations, including the Raleigh North Carolina Chapter of the Juvenile Diabetes Research Foundation and the North Carolina Methodist Home for Children, and is co-chair of the Mission of Hope for Sierra Leone, an organization dedicated to improving healthcare in Africa.
